Related Experiment Video
Updated: May 31, 2025

Methodology for Sputum Induction and Laboratory Processing
Published on: December 17, 2017
Retrospective Study of the Impact of SARS-CoV-2 Infection on Asthma Control in Children
Jaqueline Abdul-Razzak1,2, Mihaela Ionescu3, Radu Diaconu2
1Doctoral School, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
Insights
COVID-19 infection in asthmatic children can cause lasting lung function changes and persistent symptoms. Regular medical check-ups and tailored asthma treatment are crucial for managing these long-term effects.
Area of Science:
- Pediatric Pulmonology
- Infectious Diseases
- Allergy and Immunology
Background:
- Asthmatic children are a vulnerable population for respiratory infections.
- The impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on pediatric asthma is not fully understood.
- Long-term respiratory sequelae post-COVID-19 in children with asthma require investigation.
Purpose of the Study:
- To analyze the influence of SARS-CoV-2 infection on lung function and symptoms in pediatric asthma patients.
- To evaluate changes in asthma treatment and control following COVID-19.
- To identify long-term respiratory effects in asthmatic children post-SARS-CoV-2 infection.
Main Methods:
- Retrospective analysis of pediatric asthma patients (0-17 years) with and without SARS-CoV-2 infection (March 2020-July 2024).
- Data collected included demographics, allergies, exacerbations, exhaled nitric oxide, ventilatory function, and asthma control (GINA assessment).
- Statistical analysis using Mann-Whitney U, Kruskal-Wallis H, and Chi-Square tests.
Main Results:
- Increased incidence of SARS-CoV-2 cases observed in 2022 compared to 2020-2021.
- Statistically significant increases in exhaled nitric oxide (p < 0.0005) and exacerbations (p < 0.0005) in SARS-CoV-2 infected asthmatic children.
- Significant differences in ventilatory function (p < 0.05) were noted between infected and non-infected asthmatic children.
Conclusions:
- Persistent cough and altered ventilatory tests post-SARS-CoV-2 infection are significant findings in pediatric asthma.
- Periodic medical evaluations are essential for monitoring asthmatic children after COVID-19.
- Individualized therapeutic regimens are necessary to manage post-COVID-19 respiratory complications in pediatric asthma.
Abstract:
Asthmatic children who tested positive for COVID-19 experienced changes in lung function and persistent symptoms following SARS-CoV-2 infection, even for several months after diagnosis, and with the same features as in an acute phase. This study aimed to analyze a pediatric age group (between 0 and 17 years old) diagnosed with asthma, and SARS-CoV-2 infection attending regular monitoring visits in a Pediatric Department of a Regional Tertiary Hospital (Filantropia Clinical Municipal Hospital Craiova, Romania) during the COVID-19 pandemic and post-pandemic time interval (i.e., March 2020-July 2024), and identify how the infection influenced their long-term symptoms and treatment. Materials and Methods. The following variables were recorded: demographic data (gender, age group, residence), data related to allergies (allergic rhinitis, atopic dermatitis, and food allergies), the presence of exacerbations, the fraction of exhaled nitric oxide, the ventilatory function, the asthma phenotype (allergic or non-allergic), as well as the GINA assessment of asthma control at clinical visits were analyzed. SARS-CoV-2 infections were evaluated in terms of year of infection, symptoms, cough presence and persistence, and modifications of the asthma treatment during and after COVID-19 disease. The data were statistically analyzed with SPSS, using the Mann-Whitney U, Kruskal-Wallis H, and Chi-Square tests. Results. A lower incidence of COVID-19 cases was recorded in the first pandemic of asthmatic patients (2020 and 2021), but an increase in the rate of cases was observed at the beginning of the second pandemic, in 2022. The nitric oxide values in asthmatic children who were infected with SARS-CoV-2 were statistically significantly increased (p < 0.0005), especially for children with persistent cough for more than 4 weeks. A significant increase in the number of exacerbations was also observed in patients who tested positive for SARS-CoV-2 infection (p < 0.0005). Ventilatory function values were statistically significantly different in asthmatic children with and without SARS-CoV-2 infection (p < 0.05). Conclusions. The persistence of cough after the acute phase of SARS-CoV-2 infection as well as the changes in ventilatory tests emphasize the need of periodic medical check-ups, as well as the implementation of a therapeutic regimen appropriate for each pediatric patient.
More Related Videos
05:31Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
Published on: August 7, 2017
09:03Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic
Published on: November 7, 2020
Related Concept Videos
Asthma-III: Symptoms and Complications
Classification of Asthma
Asthma-I: Introduction
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Lung Capacity